Article: New prescription weight-loss medication on FDA 'fast track'

THIS ELECTRONIC VERSION MAY DIFFER SLIGHTLY FROM PRINTED VERSION

While testing a drug for Lou Gehrig's disease in the mid-1990s, scientists noticed that people receiving the drug were losing weight. It was an unexpected and unwanted side effect. They eventually concluded that the medication wasn't helpful for people with the degenerative motor neuron disease, but they didn't forget their finding.

Today, the drug, Axokine, is poised to become the next prescription weight-loss medication. In January, the Food and Drug Administration gave it "fast track" status because, by facilitating weight loss, it could reduce the risk for heart attack, stroke and diabetes in obese people. The designation ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!